Skip to main content
editorial
. 2020 Jun 12;47(9):2054–2058. doi: 10.1007/s00259-020-04910-y

Fig. 1.

Fig. 1

Total accrual to EORTC therapeutic studies in the four months prior and 4 months during COVID-19 pandemic, compared to the total recruitment over the corresponding months 1 year before